A prospective double-blind randomized placebo-controlled clinical trial to evaluate the safety and efficacy of spironolactone in patients with advanced congestive heart failure on continuous ambulatory peritoneal dialysis

Congestive heart failure (CHF) is frequent in patients with chronic renal failure, and may contribute to high cardiovascular morbidity and mortality. There is little data in the literature about the safety and efficacy of use of spironolactone in patients with end-stage renal disease with heart fail...

Full description

Bibliographic Details
Main Authors: Shahram Taheri, Mojgan Mortazavi, Ali Pourmoghadas, Shiva Seyrafian, Zeynab Alipour, Shirin Karimi
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2012-01-01
Series:Saudi Journal of Kidney Diseases and Transplantation
Online Access:http://www.sjkdt.org/article.asp?issn=1319-2442;year=2012;volume=23;issue=3;spage=507;epage=512;aulast=Taheri